Combining perfluoroalkane acid exposure levels for risk assessment.
暂无分享,去创建一个
[1] C. Lau,et al. Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[2] N. Kudo,et al. Sex hormone-regulated renal transport of perfluorooctanoic acid. , 2002, Chemico-biological interactions.
[3] John W. Froehlich,et al. Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers , 2007, Environmental health perspectives.
[4] A. Starkov,et al. Structural determinants of fluorochemical-induced mitochondrial dysfunction. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[5] D. Waxman,et al. trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[6] Safe,et al. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. , 1998, Environmental health perspectives.
[7] R. G. York,et al. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. , 2005, Toxicology.
[8] R. E. Staples,et al. The embryo-fetal toxicity and teratogenic potential of ammonium perfluorooctanoate (APFO) in the rat. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[9] A. Calafat,et al. Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES). , 2007, Environmental science & technology.
[10] Jeffrey H Mandel,et al. Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. , 2004, Chemosphere.
[11] B. Abbott,et al. Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors ( , / , ) by Perfluorooctanoic Acid and Perfluorooctane Sulfonate , 2006 .
[12] M. A. Mohd,et al. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. , 2004, Environmental science & technology.
[13] A. Calafat,et al. Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. , 2006, Environmental science & technology.
[14] J. V. Vanden Heuvel,et al. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[15] David J. Waxman,et al. trans-Activation of PPARα and Induction of PPARα Target Genes by Perfluorooctane-Based Chemicals , 2004 .
[16] Gerald L Kennedy,et al. The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. , 2004, Toxicology.
[17] C. Lau,et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[18] Andrew C. Li,et al. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis Published, JLR Papers in Press, October 16, 2004. DOI 10.1194/jlr.R400010-JLR200 , 2004, Journal of Lipid Research.
[19] L S Birnbaum,et al. Developmental toxicity of perfluorodecanoic acid in C57BL/6N mice. , 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[20] John P. Vanden Heuvel,et al. Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-α, -β, and -γ, Liver X Receptor-β, and Retinoid X Receptor-α , 2006 .
[21] G. Kennedy,et al. Absorption, Distribution, and Excretion of Ammonium Perfluorooctanoate (APFO) After Oral Administration to Various Species , 2006, Drug and chemical toxicology.
[22] K. Helzlsouer,et al. Historical Comparison of Perfluorooctanesulfonate, Perfluorooctanoate, and Other Fluorochemicals in Human Blood , 2005, Environmental health perspectives.
[23] K. Wallace,et al. Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis. , 2002, Toxicology letters.
[24] C. Tohyama,et al. The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[25] J M Rogers,et al. Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. , 2005, Birth defects research. Part B, Developmental and reproductive toxicology.
[26] Jeffrey H Mandel,et al. Characterization of risk for general population exposure to perfluorooctanoate. , 2004, Regulatory toxicology and pharmacology : RTP.
[27] C. Lau,et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[28] Jeffrey H Mandel,et al. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. , 2003, Environmental health perspectives.